A new "tumor-on-a-chip" model is giving scientists a live look at how pancreatic cancer can recruit the body's own immune ...

A research team led by Professor Yoosoo Yang (Department of Integrative Biotechnology) of Sungkyunkwan University, in ...

AI success depends on whether enterprise data is ready, reachable, and close enough to the workloads that need it. In this eSpeaks episode, Dell Technologies’ Vrashank Jain explains why fragmented ...

Washington DC [US], July 7 (ANI): Scientists have identified a molecular switch that could help explain why colorectal cancer ...

Researchers say approach could be useful for both initial treatment of bladder cancer as well as treatment refractory subsets of tumors.

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

Cancer cells that disseminate from a tumor can enter a period of dormancy that may persist from months to decades before metastasis. Efforts to improve adjuvant therapy to remove residual cancer cells ...

Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others.

A new CRISPR-based method increases protein production in a targeted manner, bringing new insights to stem cell biology and ...